2؉ signaling may contribute to tumorigenesis and the mechanism of action of some anticancer drugs. The plasma membrane calcium-ATPase (PMCA) is a crucial controller of intracellular Ca 2؉ signaling. Altered PMCA expression occurs in the mammary gland during lactation and in breast cancer cell lines. Despite this, the consequences of PMCA inhibition in breast cancer cell lines have not been investigated. In this work, we used Tet-off PMCA antisense-expressing MCF-7 cells to assess the effects of PMCA inhibition in a human breast cancer cell line. At a level of PMCA inhibition that did not completely prevent PMCA-mediated Ca 2؉ efflux and did not induce cell death, a dramatic inhibition of cellular proliferation was observed. Fluorescence-activated cell sorting analysis indicated that PMCA antisense involves changes in cell cycle kinetics but not cell cycle arrest. We concluded that modulation of PMCA has important effects in regulating the proliferation of human breast cancer MCF-7 cells.
Alterations in Ca
2؉ signaling may contribute to tumorigenesis and the mechanism of action of some anticancer drugs. The plasma membrane calcium-ATPase (PMCA) is a crucial controller of intracellular Ca 2؉ signaling. Altered PMCA expression occurs in the mammary gland during lactation and in breast cancer cell lines. Despite this, the consequences of PMCA inhibition in breast cancer cell lines have not been investigated. In this work, we used Tet-off PMCA antisense-expressing MCF-7 cells to assess the effects of PMCA inhibition in a human breast cancer cell line. At a level of PMCA inhibition that did not completely prevent PMCA-mediated Ca 2؉ efflux and did not induce cell death, a dramatic inhibition of cellular proliferation was observed. Fluorescence-activated cell sorting analysis indicated that PMCA antisense involves changes in cell cycle kinetics but not cell cycle arrest. We concluded that modulation of PMCA has important effects in regulating the proliferation of human breast cancer MCF-7 cells.
Free intracellular Ca
2ϩ , acting as a second messenger, is crucial for a diverse range of biological functions, such as fertilization, neurotransmission, muscle contraction, and gene transcription (1, 2) . Intracellular Ca 2ϩ signaling is also a key regulator of proliferation (3), cell cycle progression (4) , and apoptosis (5) . Modulation of capacitative Ca 2ϩ entry, a mechanism whereby the influx of extracellular Ca 2ϩ is coupled to the depletion of intracellular Ca 2ϩ stores within the endoplasmic reticulum, is associated with the proliferative phenotype (6) . Indeed, blockers of Ca 2ϩ entry may be potential anti-proliferative agents (7, 8) . Inhibition of Ca 2ϩ /calmodulin-dependent serine/threonine protein kinase II also arrests HeLa cells in the G 2 phase of the cell cycle (9) , and apoptotic resistance conferred by overexpression of the anti-apoptotic oncoprotein Bcl-2 involves modulation of Ca 2ϩ handling by the endoplasmic reticulum (5) and capacitative Ca 2ϩ entry (10, 11) . Although the essential role of Ca 2ϩ signaling in maintaining homeostatic functions is well established, less is known about the role of aberrant Ca 2ϩ signaling in disease (12, 13) . The plasma membrane Ca 2ϩ -ATPase (PMCA), 1 or pump, belongs to the family of P-type ATPases and is a critical regulator of free intracellular Ca 2ϩ (14) . It actively extrudes Ca 2ϩ across the plasma membrane and is important for maintaining basal cytosolic Ca 2ϩ levels and lowering free intracellular Ca 2ϩ after the generation of Ca 2ϩ transients and other Ca 2ϩ signaling events (2, 15) . PMCA has important roles in shaping the dynamics of Ca 2ϩ signaling, as its activation can limit Ca 2ϩ influx during capacitative Ca 2ϩ entry (16) . Moreover, PMCA overexpression decreases both the amplitude and duration of cytosolic Ca 2ϩ responses after agonist-induced stimulation (17) .
There are four isoforms of PMCA (PMCA1-4) with additional isoform diversity generated by alternative splicing from the primary PMCA transcripts (14, 18) . Up-regulation of PMCA2 and down-regulation of PMCA4 in the rat mammary gland during lactation may indicate that PMCA isoforms regulate differentiation and proliferation of the mammary gland (19) .
There is also an increasing awareness that PMCA alterations are associated with tumorigenesis, including that of the mammary gland (20) . Indeed, relative PMCA1 mRNA expression is greater in tumorigenic breast cancer MCF-7 and MDA-MB-231 cells than that in non-tumorigenic MCF-10A cells (21) . PMCA1 and PMCA4 expression is also lower in simian virus 40-transformed human skin fibroblasts (22) . Thus, perturbed PMCA regulation or function may be important in diseases such as cancer. Therapeutic modulation of PMCA expression and/or activity may have functional consequences in suppressing the tumorigenic phenotype. The appropriateness of PMCA as a possible drug target is also demonstrated by the prominence of other clinically used inhibitors of P-type ATPases, digoxin and omeprazole, as inhibitors of Na ϩ /K ϩ -ATPase and H ϩ /K ϩ -ATPase, respectively (23, 24) . Despite the dynamic regulation of PMCA expression in the mammary gland, the consequences of PMCA inhibition in breast cancer cell lines has not been addressed. Our aim was to investigate whether PMCA inhibition alters Ca 2ϩ homeostasis, cell proliferation, and cell death in MCF-7 human breast cancer cells.
EXPERIMENTAL PROCEDURES
Cell Culture-MCF-7 Tet-off cells (Clontech) were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 4 mM L-glutamine, 100 g/ml G418, 100 units/ml penicillin G, and 100 g/ml streptomycin with the addition of 110 g/ml hygromycin B and 100 ng/ml doxycycline (DOX) as required. All cultures were maintained at 37°C in a humidified 5% CO 2 /95% air incubator.
Construction of PMCA Antisense cDNA and Cloning-A 286-basepair cDNA fragment was amplified by reverse transcription-PCR from MCF-7 Tet-off cells and cloned into the bidirectional pBI-G response plasmid (Clontech) to generate the PMCA antisense construct. The following primers were used to amplify the cDNA fragment: forward primer, 5Ј-TAGGTCGACGAAATGTCTATGACAGCAT-3Ј; and reverse primer, 5Ј-TAGGTCGACGGGCCCATTATCTTCTTCATCAT-3Ј. These primers were based on sequence information that is conserved across all human PMCA isoforms. A SalI restriction enzyme site (italics) was introduced into each primer to facilitate cloning, and an ApaI site (underlined) was incorporated into the reverse primer to assist in directional cloning. The PCR product was digested with SalI and inserted into the SalI site of the pBI-G plasmid in the antisense orientation. Following nucleotide sequencing of the antisense construct, the cDNA fragment sequence was compared against GenBank TM using BLAST version 2.2.8.
Generation of a Double Stable MCF-7 Tet-off PMCA Antisensetransfected Cell Line-Parental MCF-7 Tet-off cells already stably transfected with the regulatory tetracycline-controlled transactivator were co-transfected using Lipofectamine 2000 (Invitrogen) with the prepared pBI-G PMCA antisense plasmid and the pTK-Hyg hygromycin B resistance plasmid (Clontech). Hygromycin B-resistant clones were isolated (total of 43) and screened for tetracycline-regulated ␤-galactosidase expression. ␤-Galactosidase acted as an indirect reporter for the simultaneous expression of PMCA antisense RNA when DOX was removed from the culture medium. Screening was performed using the ␤-galactosidase enzyme assay system with reporter lysis buffer in accordance with the manufacturer's instructions (Promega, Annandale, New South Wales, Australia). Eight colonies that showed differing degrees of tetracycline-regulated ␤-galactosidase activity (2-10-fold increases upon DOX removal) were further screened for their effect on PMCA protein with the non-isoformspecific PMCA antibody 5F10. From these colonies, three clones were assessed in subsequent proliferation assays and from the three, one clone (A7) was selected for more detailed characterization.
Proliferation Assays-Cells were plated at 800 cells/well in 96-well plates by initially seeding them in DOX-and hygromycin B-free medium (100 l/well). DOX was then added to or omitted from the wells at the time of plating (day 0). The cells were grown over a 2-week period with the medium renewed every 2-3 days, except on the last day of the experiment. The proliferation of viable cells was monitored daily from days 3 to 13 via a colorimetric MTS assay (25) by directly adding CellTiter 96® AQueous One Solution reagent (20 l; Promega) to each well and incubating plates for 2 h at 37°C in a humidified 5% CO 2 /95% air environment. After 2 h, absorbances were read at 490 nm with a Bio-Rad Model 550 microplate reader.
Immunoblotting-Protein was isolated from cells plated into 10-cm diameter dishes at 1 ϫ 10 5 cells/dish. The cells were seeded in DOXand hygromycin B-free medium and then were adjusted at the time of plating to include hygromycin B, either with or without DOX (100 ng/ml). On days 3, 7, and 13, the cells were trypsinized and stored as cell pellets at Ϫ80°C until further processing for total protein isolates. Total protein was analyzed by immunoblotting, as described previously (26) . For each sample, 40 g of total protein was loaded onto 7.5% gels. Antibodies were used at the following dilutions and incubated for 1 h at room temperature: 1:2000 for 5F10 (Affinity BioReagents, Golden, CO), 1:1000 for JA9 (kind gift from Dr. John T. Penniston, Department Biochemistry and Molecular Biology, Mayo Foundation, Rochester, MN), 1:1000 for NR1 (Affinity BioReagents), 1:1000 for NR2 (Affinity BioReagents), 1:1000 for IID8 (Affinity BioReagents), and 1:10,000 for anti-␤-actin (AC-15, Sigma). A goat anti-mouse or goat anti-rabbit IgG horseradish peroxidase-conjugated secondary antibody (Bio-Rad) was diluted 1:2000 or 1:1000, respectively, and used as required with incubations for 1 h at room temperature. Proteins were visualized via enhanced chemiluminescence (ECL TM , Amersham Biosciences). Densitometry measurements of immunoblot bands were analyzed using MetaMorph® version 4.01 imaging software (Universal Imaging Corporation, Downingtown, PA). For each immunoblot, the optical density values for bands representing total PMCA, PMCA4, PMCA1, PMCA2, and SERCA2 were normalized to the corresponding value for the ␤-actin band in each lane.
Fluorescence-activated Cell Sorting (FACS) Analysis of DNA Content-Cells were plated at 5 ϫ 10 5 cells/dish in 10-cm diameter dishes, in DOX-and hygromycin B-free medium and then grown in either the presence or absence of DOX. On days 7 and 13, the cells were harvested from the dishes by collecting trypsinized cells together with floating cells in the medium. For each condition, a volume of the cell suspension corresponding to 2 ϫ 10 6 cells was centrifuged, and the resultant cell pellet was resuspended in ice-cold phosphate-buffered saline (0.5 ml). The cells were fixed in ice-cold 70% ethanol and stained with propidium iodide. FACS analysis was performed using a BD Biosciences FACSCalibur TM flow cytometer. DNA content histograms and cell cycle phase distributions were modeled from at least 10,000 single events by excluding the cell aggregates based on scatter plots of the fluorescence pulse area versus fluorescence pulse width using ModFit LT TM version 2.0 (Mac) software (Verity Software House, Topsham, ME).
5-Bromo-2Ј-deoxyuridine (BrdUrd) Pulse-Chase Analysis of Cell Cycle Progression-Cells that had been growing in the presence or absence of DOX-containing medium for 6 days were plated at 1 ϫ 10 6 cells/dish in 10-cm diameter dishes. After a further 24 h in the appropriate medium (ϮDOX), the cells were pulsed with either Dulbecco's phosphate-buffered saline or 5-bromo-2Ј-deoxyuridine 10 M (BrdUrd) for 1 h, followed by one wash with Dulbecco's phosphate-buffered saline. After washing, the cells were then maintained in the appropriate medium (ϮDOX) until being trypsinized, centrifuged at 300 ϫ g for 5 min, and fixed at 0, 3, 6, 12, and 24 h post-BrdUrd pulse. Collected cells were fixed and stained with the BD Biosciences fluorescein isothiocyanate BrdUrd flow kit, according to the manufacturer's instructions. Briefly, paraformaldehyde-fixed and saponin-permeabilized cells were incubated for 1 h at 37°C with DNase (300 g/ml in Dulbecco's phosphatebuffered saline). BrdUrd and total DNA were then stained with a fluorescein isothiocyanate-conjugated anti-BrdUrd antibody and 7-amino-actinomycin D (7-AAD), respectively. Data were acquired using a BD Biosciences FACSCalibur TM flow cytometer with BD Biosciences CellQuest TM version 3.3 software. For each sample, data were displayed using WinMDI version 2.8 (Joseph Trotter, facs.scripps.edu/software.html) by first gating at least 10,000 events to select a population of single cells based on density plots of the 7-AAD fluorescence pulse area (FL3-A) versus the 7-AAD fluorescence pulse width (FL3-W). Using this subpopulation of cells, density plots of fluorescein isothiocyanate-conjugated anti-BrdUrd antibody fluorescence pulse height (FL1-H) versus 7-AAD fluorescence pulse height (FL3-H) were generated. Negative BrdUrd controls, where cells were pulsed with Dulbecco's phosphate-buffered saline, were used to set the positions of quadrant markers.
Assessment of Cell Morphology-Double stable MCF-7 Tet-off PMCA antisense-transfected cells were plated onto 25-mm diameter coverslips placed in a 6-well plate at 1.8 ϫ 10 4 cells/well and grown either in the presence or absence of DOX. On day 13 of the culture, phase contrast images at 200ϫ magnification were taken from five random fields using a Nikon Eclipse TE300 microscope (Nikon Instech, Kawasaki, Japan) and MetaFluor® version 4.01 imaging software (Universal Imaging Corporation, Downingtown, PA).
Assessment of Calcium Efflux-The efflux of free intracellular Ca 2ϩ was assessed using a fluorescence microplate reader to monitor the rate of decline in free intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) after the generation of ionomycin-induced Ca 2ϩ transients that ranged in magnitude with varying concentrations of the Ca 2ϩ ionophore. Subconfluent double stable MCF-7 Tet-off PMCA antisense cells grown in DOX were subcultured at a split ratio of 1:10 into new T-75 cm 2 flasks containing fresh medium, either with or without DOX (100 ng/ml), and grown for 6 days. After 6 days, the cells were plated into polystyrene 96-well plates at 4 ϫ 10 4 cells/well in growth medium (100 l/well) with or without DOX, as previously treated. The cells were allowed to adhere for 24 h before loading the cells with the non-ratiometric Ca 2ϩ indicator fluo-4 AM (8 M; Molecular Probes, Eugene, OR) in the loading buffer. The loading buffer (pH 7.3) was composed of 5.9 mM KCl, 1.4 mM MgCl 2 , 10 mM HEPES, 1.2 mM NaH 2 PO 4 , 5 mM NaHCO 3 , 140 mM NaCl, 11.5 mM glucose, 1.8 mM CaCl 2 , and 3 mg/ml bovine serum albumin. The cells were loaded at 37°C for 30 min and washed once with loading buffer (no indicator) and once with physiological salt solution (PSS). PSS (pH 7.3) contained 5.9 mM KCl, 1.4 mM MgCl 2 , 10 mM HEPES, 1.2 mM NaH 2 PO 4 , 5 mM NaHCO 3 , 140 mM NaCl, 11.5 mM glucose, and 1.8 mM CaCl 2 . The cells were then incubated for 15 min in PSS at room temperature (21 Ϯ 2°C) to minimize indicator leakage and sequestration into intracellular organelles. The PSS was removed, and the cells were washed once with loading buffer and then twice with PSS in which NaCl was replaced with an equimolar amount of N-methyl-D-glucamine and CaCl 2 was excluded (Na ϩ /Ca 2ϩ -free PSS). Cells loaded with fluo-4 were stimulated with 50 -420 nM ionomycin in Na ϩ /Ca 2ϩ -free PSS containing 100 M BAPTA (Molecular Probes) and 5 M cyclopiazonic acid to obtain various levels of peak [Ca 2ϩ ] i and establish a Ca 2ϩ efflux profile curve. A calcium chelator, BAPTA was included to block Ca 2ϩ influx (27) , and the addition of cyclopiazonic acid prevented Ca 2ϩ sequestration into the endoplasmic reticulum by SERCA; this concentra-
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tion was selected based on previous studies (28) and after cyclopiazonic acid dose response curves were generated in MCF-7 cells (data not shown). Na ϩ /Ca 2ϩ -free PSS was used throughout the experiment to prevent the Na ϩ /Ca 2ϩ exchanger from contributing to Ca 2ϩ efflux (27, 29) . Hence the rate of decline in [Ca 2ϩ ] i was predominately a measure of PMCA-mediated free intracellular Ca 2ϩ efflux. Experiments were performed using a NOVOstar® fluorescence microplate reader (BMG LabTechnologies, Offenburg, Germany). Fluo-4 was excited at 485 nm, and fluorescence emission was detected at 520 nm. Fluo-4 fluorescence data points were acquired every 1.5 s. All experiments were performed at 31 Ϯ 1°C. Relative changes in [Ca 2ϩ ] i using fluo-4 were determined by calculations of ⌬F/F, where ⌬F/F ϭ (F t Ϫ F 0 )/F 0 . In this equation, F t equals the fluorescence reading at each time point (t), and F 0 represents initial fluorescence at t ϭ 0 (30). For each well, where peak [Ca 2ϩ ] i was obtained within 90.5 s following the addition of ionomycin, the fluorescence data corresponding to the 60 s after and including the peak ⌬F/F was fitted to a monoexponential curve as a measure of the rate of PMCA-mediated free intracellular Ca 2ϩ efflux (29) . Statistical Analyses-All data points are presented as means Ϯ S.D., unless otherwise stated, for the number of replicates (n) indicated. Meaningful comparisons between groups were analyzed for statistical significance using a two-sided Student's t test with significance set at p Ͻ 0.05.
RESULTS

PMCA Antisense Induction Suppresses Proliferation of MCF-7 Tet-off Breast Cancer Cells-To generate a cell line
where PMCA antisense could be tightly controlled and equivalent levels of expression could be obtained, we generated a MCF-7 Tet-off PMCA antisense cell line, where the removal of DOX induced PMCA antisense expression (see "Experimental Procedures"). Based upon initial screening for tetracyclineregulated ␤-galactosidase expression as a marker for the simultaneous expression of PMCA antisense and the sensitivity of PMCA expression to doxycycline removal, proliferation assays were conducted for three MCF-7 Tet-off PMCA antisensetransfected clones. All three clones exhibited inhibition of proliferation upon antisense induction, and one clone (A7) was selected for more detailed characterization. The effect of antisense expression on proliferation is shown in Fig. 1A for A7. Controls included identical experiments using parental MCF-7 Tet-off cells (Fig. 1B) and a MCF-7 Tet-off cell line with regulated expression of both ␤-galactosidase and a protein unrelated to PMCA (Fig. 1C) . The induction of PMCA antisense (DOX absence) profoundly suppressed the proliferation of MCF-7 (A7) cells over a period of 13 days (Fig. 1A) . The removal of DOX did not affect the proliferation of the controls (Fig. 1, B  and C) .
Effect of PMCA Antisense Induction on PMCA Protein Expression-To evaluate whether tetracycline-regulated PMCA antisense inhibits PMCA protein expression, we used immunoblotting (Fig. 2) to probe for total PMCA protein using the non-isoform-specific 5F10 antibody and isoform-specific antibodies to PMCA4, PMCA1, and PMCA2 (31). Immunoblots were repeated twice for two independent sets of protein isolated from MCF-7 (A7) cells. A representative immunoblot is shown for total PMCA protein ( Fig. 2A) . As shown by densitometry measurements, a significant (p ϭ 0.005) decrease in total PMCA protein expression was observed on day 13 in cells expressing PMCA antisense (DOX absence) compared with no antisense-expressing cells (DOX presence) (Fig. 2B) . Relative PMCA4 levels increased with days in culture, implicating a potential role for PMCA4 in proliferation, and this increase was inhibited in cells expressing antisense (Fig. 2, C and D) . By day 13 of growth, PMCA4 protein expression was significantly (p ϭ 0.007) lower in PMCA antisense-induced MCF-7 (A7) cells, in contrast to the parallel non-induced control (Fig. 2D) . We also showed for the first time, PMCA1 and PMCA2 protein in MCF-7 cells (Fig. 2, E and G) . PMCA1 was only modestly increased in relative expression with days in culture, which 
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was not significantly attenuated by PMCA antisense (Fig. 2 , E and F). Consistent with its likely role in specific cellular functions, such as lactation (19, 32) , PMCA2 levels did not alter with days in culture and proliferation (Fig. 2, G and H) . Effect of PMCA Antisense Induction on SERCA2 Protein Expression-Due to the regulatory link between PMCA and SERCA expression (33), we assessed the effects of PMCA antisense-mediated inhibition of MCF-7 cell proliferation on SERCA2 expression. The modest increase in SERCA2 expression at day 13 was attenuated when MCF-7 cell proliferation was inhibited via PMCA antisense (Fig. 3) .
PMCA Antisense Induction Alters Cell Cycle Phase Distribution-We next investigated the effect of PMCA antisense on cell cycle phase distribution by performing FACS analysis of DNA content using asynchronous cultures of MCF-7 (A7) cells, which were grown in either the presence or absence of DOX for 7 and 13 days. Fig. 4 shows (for each growth condition) percentages of the total number of cells modeled that were present in G 0 /G 1 , S, or G 2 /M phases of the cell cycle. There were no significant differences in the percentage of cells in G 0 /G 1 phase between MCF-7 (A7) cells grown in either the presence or absence of DOX for both 7 and 13 days (Fig. 4A) . However, PMCA antisense induction significantly (p ϭ 0.005, day 7; p ϭ 0.006, day 13) decreased the percentage of cells present in S phase (Fig. 4B) . PMCA antisense induction also significantly (p ϭ 0.008, day 7; p ϭ 0.013, day 13) increased the percentage of cells in G 2 /M phase (Fig. 4C) . FACS analysis revealed the absence of a noticeable sub-G 0 /G 1 peak, at either day 7 or 13, in a set of propidium iodide-stained PMCA antisense-induced MCF-7 (A7) cells (data not shown).
To further assess the mechanism by which PMCA antisense induction inhibited the proliferation of MCF-7 (A7) cells, we conducted BrdUrd pulse-chase experiments. Results (Fig. 5) are representative of two independent experiments. PMCA antisense induction (DOX absence) in MCF-7 (A7) cells resulted in fewer BrdUrd-positive cells at 0 h after the BrdUrd pulse (12-12.9%) compared with the controls (DOX presence; 26 -26.8%). This is consistent with the significant reduction of S phase cells, as previously shown in Fig. 4B . At 6 h post-pulse, cells were progressing into G 2 /M in both control and antisenseinduced groups. At 12 h, the emergence of a BrdUrd-positive peak with a G 0 /G 1 DNA content in both PMCA antisenseinduced (DOX absence) and -non-induced controls (DOX presence) indicated that PMCA antisense-induced cells were still actively transiting S and G 2 /M phases (Fig. 5A) . Thus PMCA antisense expression in MCF-7 (A7) cells did not result in S or G 2 /M phase arrest. At 24 h post-pulse, PMCA antisense induction resulted in fewer BrdUrd-positive cells with a G 0 /G 1 DNA content (11.3-12 .4%) compared with controls (26.2-27.5%), indicating a slower transition through G 2 /M phase. No apparent differences in S and G 2 /M phase progression were found for parental MCF-7 Tet-off cells at the 0, 6, and 12 h time points (data not shown) or the 24 h time point (Fig. 5B) .
Induction of PMCA Antisense Inhibits PMCA-mediated Efflux of Free Intracellular Calcium-The effect of PMCA antisense on the primary functional role of PMCA was assessed by comparing the rate of PMCA-mediated efflux of free intracellular Ca 2ϩ between MCF-7 (A7) cells that were cultured either with or without DOX for 7 days (Fig. 6 ). Data were obtained by stimulating Ca 2ϩ transients with ionomycin (50 -420 nM) and then monitoring PMCA-mediated declines in [Ca 2ϩ ] i between pairs of wells containing either PMCA antisense-induced or -non-induced MCF-7 (A7) cells. Ionomycin was selected to reduce the activation of other pathways known to alter PMCA activity (28, 34) . Ca 2ϩ transients induced by 300 nM ionomycin and subsequent declines in DF/F, as a measure of relative change in [Ca 2ϩ ] i , show that, at this level of PMCA antisense induction, cells could still recover to basal levels of [Ca 2ϩ ] i after Ca 2ϩ ionophore-induced increases (Fig. 6A) . However, cells expressing PMCA antisense (DOX absence) had a slower rate of PMCA-mediated free intracellular Ca 2ϩ efflux. This is illustrated by comparisons of the rate of PMCA-mediated decline in [Ca 2ϩ ] i between antisense-expressing cells and cells with no antisense induction at similar levels of peak relative [Ca 2ϩ ] i (Fig. 6B) . To assess the effects of PMCA inhibition on the calcium homeostasis changes induced by physiological stimuli, the peak responses to the purinergic receptor activator ATP (100 mM) were assessed. PMCA inhibition increased peak responses to this stimulus (Fig. 6C) .
PMCA Antisense Induction Alters the Morphology of MCF-7 Tet-off Cells-Phase contrast images of MCF-7 (A7) cells plated at the same cell density and then grown for 13 days, either in the presence or absence of DOX, were taken from five random fields (Fig. 7) . PMCA antisense-induced cells (DOX absence) were subconfluent (Fig. 7B ) compared with antisense-non-induced controls (DOX presence) (Fig. 7A) . Moreover, a proportion of MCF-7 (A7) cells with PMCA antisense induction exhibited a large, rounded, and flat cell morphology (Fig. 7B) , similar to that we have previously observed for the non-tumorigenic, "normal" breast cell line MCF-10A (data not shown).
DISCUSSION
Intracellular Ca 2ϩ signaling is essential for a diverse array of cellular functions and regulates processes that control both (35) . The versatility of Ca 2ϩ signaling in terms of spatial and temporal regulation is believed to form the basis of how fluctuations in [Ca 2ϩ ] i are able to encode a diverse array of specific messages controlling many cellular functions. For instance, changes in the amplitude and duration of Ca 2ϩ signals can mediate the specificity and efficiency in activating different transcription factors (36) , and PMCA is likely to play a key role in these events. We sought to investigate the effects of inhibiting PMCA, a critical regulator of intracellular Ca 2ϩ signaling (14) , in MCF-7 human breast cancer cells using a tetracycline-regulated antisense approach. PMCA antisense induction, at levels that do not completely block recovery of [Ca 2ϩ ] i after stimulation and do not induce cell death, suppresses cell proliferation, affects cell cycle progression, and alters cell morphology in MCF-7 cells.
Plasma Membrane Ca
PMCA plays an important physiological role in the mammary gland. PMCA4 protein from the rat mammary gland increases throughout pregnancy up until parturition and then sharply declines at the start of lactation (19) . PMCA2 protein expression, however, rises during lactation and is particularly enriched in milk fat globule membranes that originate from apical membranes of mammary gland secretory cells (19) . Notably, lactating PMCA2 null mice exhibit deficiencies in the Ca 2ϩ enrichment of milk (32) . PMCA is thus likely to be an important mediator of mammary gland physiology.
We used a tetracycline-regulated antisense approach to assess the functional consequences of PMCA inhibition in the MCF-7 human breast cancer cell line. This approach was necessary because of the current lack of a highly specific pharmacological inhibitor of PMCA. Other commonly used pharmacological agents include orthovanadate ([VO 3 (OH)] 2Ϫ ), which is a general inhibitor of all P-type ATPases (14) , and lanthanum (La 3ϩ ), which has been used to inhibit PMCA-mediated Ca 2ϩ efflux (37); but at high concentrations of lanthanum, there may also be inhibition of Ca 2ϩ efflux mediated by the Na ϩ /Ca 2ϩ exchanger (34) . Stable antisense approaches have been used previously by others to study the functional role of PMCA. For instance, inhibition of PMCA1 expression in PC6 pheochromocytoma cells via stable antisense hinders neuronal differentiation and neurite extension in response to nerve growth factor (38) . A tetracycline-regulated approach to antisense expression possesses advantages over the use of antisense oligonucleotides or transient siRNA transfection. It bypasses the issues surrounding inefficient and variable uptake (39) , which may cause either partial or complete inhibition of expression in some cells. A transient transfection would make it difficult to confirm whether decreased proliferation is because of partial target inhibition or complete inhibition in some cells. Moreover, the stable expression of antisense under the control of a tetracycline-regulated promoter also allows for the long term inhibition of protein expression (40) , which is of particular relevance for proteins with relatively long half-lives (41) . Indeed, the half-life of PMCA has been reported to be ϳ12 days (42) . Moreover, the ability to induce antisense expression only during experiments and not during colony selection or culture maintenance reduces the likelihood of very long term adaptive changes to signaling pathways. Our findings show that the induction of PMCA antisense in the MCF-7 breast cancer cell line profoundly suppresses cell proliferation (Fig. 1A) , being neither a nonspecific effect of DOX removal from the culture medium (Fig. 1B) nor a random effect of expression from a tetracycline-regulated promoter (Fig. 1C) . Immunoblot densitometry measurements indicated that 
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PMCA antisense induction inhibited total PMCA protein expression (Fig. 2, A and B) . Our studies also demonstrated for the first time PMCA1, PMCA4, and PMCA2 protein expression in MCF-7 cells. This places the well characterized MCF-7 cell line as an outstanding tool to explore the role of individual PMCA isoforms in specific signaling pathways and functions. The relatively long half-life of PMCA (42) may account for a significant difference in the PMCA protein level being evident only after extended days of culture and suggests that the inhibition of new PMCA protein synthesis regulates the observed effect on cell proliferation. Even when PMCA-mediated free intracellular Ca 2ϩ efflux is inhibited to levels that allow recovery of [Ca 2ϩ ] i (Fig. 6A) , we saw dramatically reduced cell proliferation, identifying PMCA as a potential drug target in breast cancer. Indeed, the non-estrogen-mediated effects of tamoxifen have been likened to the augmentation of Ca 2ϩ responses (43) , an effect which would also arise from the inhibition of PMCA. 
FACS analysis showed that PMCA antisense induction did not result in apparent apoptotic cell death compared with noninduced controls; rather antisense affected the S and G 2 /M phases of the cell cycle. FACS analysis of DNA content alone (Fig. 4) did not indicate whether this effect was because of a slow down in cell cycle progression or an arrest in a particular phase. BrdUrd pulse-chase studies showed that the duration for which cells resided in the G 2 /M phase was increased by PMCA antisense and that cells were still able to transit S and G 2 /M phases of the cell cycle (Fig. 5) . Thus the effect of PMCA antisense on the cell cycle involves changes in cell cycle kinetics rather than cell cycle arrest. Phase contrast images depicting confluence of cell cultures and cell morphology (Fig. 7 ) not only confirm that PMCA antisense inhibits cell proliferation but also results in some cells acquiring an enlarged, rounded, and flattened appearance characteristic of normal breast epithelia Tet-off PMCA antisense cells (clone A7) were plated onto coverslips placed in a 6-well plate at 1.8 ϫ 10 4 cells/well and then cultured in either the presence (ϩ) or absence (Ϫ) of doxycycline (DOX; 100 ng/ml). After 13 days of growth, images of cells at 200ϫ magnification were taken from five random fields. A, the panels on the left are images of cells grown in the presence of doxycycline (ϩDOX; no antisense). B, the panels on the right are images of cells grown in the absence of doxycycline (ϪDOX; antisense). (44) . The effect of PMCA antisense is likely to act on the G 2 /M phase to slow down cell cycle progression and may even induce senescence in breast epithelial cells.
To evaluate whether the induction of PMCA antisense affected PMCA function and not only protein expression, we assessed the relative rates of PMCA-mediated intracellular Ca 2ϩ efflux in PMCA antisense-expressing and -non-expressing MCF-7 cells (Fig. 6B) . The suppression of cell proliferation by PMCA antisense induction correlated with the inhibition of PMCA-mediated intracellular Ca 2ϩ efflux. Although PMCA antisense altered PMCA-mediated intracellular Ca 2ϩ efflux, this degree of antisense induction did not affect the apparent ability of the cell to eventually recover basal intracellular Ca 2ϩ levels after ionomycin-induced increases in [Ca 2ϩ ] i (Fig. 6A) . This may explain why suppression of cell proliferation was observed upon PMCA antisense induction, without the concomitant presence of noticeable cell death. Indeed ATP-induced calcium signaling remained during partial PMCA inhibition, although as predicted, when calcium efflux is reduced, peak calcium responses were augmented (Fig. 6C) . Collectively, our results suggest that moderate changes in PMCA-mediated Ca 2ϩ efflux can lead to profound cellular consequences, despite the absence of major deleterious effects on global intracellular Ca 2ϩ homeostasis. It also supports the possibility of how alterations in PMCA function may affect the kinetics of Ca 2ϩ signals in specifically regulating various cellular processes such as proliferation (3). The complex dynamic aspects of intracellular Ca 2ϩ signaling in regulating transcription factors has been an area of active research (1, 2) and represents a link by which PMCA-mediated modulation of Ca 2ϩ signaling could control gene transcription and cell phenotype. Indeed, frequency modulation of Ca 2ϩ signals can regulate the activity of nuclear factor B (NFB) (45), a key transcription factor that is important in the control of proliferation in lymphocytes and is also abnormally expressed in breast cancer (46) .
There is a growing body of evidence suggesting PMCA plays important functional roles in the breast. Our data support this notion, and although inhibition of PMCA-mediated Ca 2ϩ efflux may limit breast cancer cell line proliferation alone, compromised PMCA function may be able to augment cytotoxic Ca 2ϩ responses together with other existing anti-tumor agents like tamoxifen (43) . This and the consequences of inhibiting specific PMCA isoforms in MCF-7 cells warrant further investigation.
